microbiologist at laboratory work

BioLife Products Embedded in Cook MyoSite Phase 3 Cell Therapy Trial for Stress Urinary Incontinence

BioLife Solutions, Inc.(BioLife, a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, announced that its media products are embedded into the autologous cell therapy being developed by Pittsburgh-based Cook MyoSite, a subsidiary of the Cook Group, for treatment of female stress urinary incontinence.  Read more.

Source: PharmaBiz.com, July 19, 2016

Posted in News and tagged , , , , .